Most Older Adults Willing to Play Game to Monitor Vision

This article originally appeared here.
Share this content:
Most Older Adults Willing to Play Game to Monitor Vision
Most Older Adults Willing to Play Game to Monitor Vision

THURSDAY, Nov. 30, 2017 (HealthDay News) -- Many older patients with age-related macular degeneration (AMD) use personal electronic devices, and most are willing to play a game to monitor vision, according to a study published online Nov. 13 in Clinical & Experimental Ophthalmology.

Hessom Razavi Franzco, M.B.B.S., from the Royal Victorian Eye and Ear Hospital in Melbourne, Australia, and colleagues conducted a single-center descriptive study involving 140 participants aged over 50 years of age (mean age, 70.5 years) with a diagnosis of intermediate AMD and best-corrected visual acuity of ≥6/12 in each eye. Participants were surveyed with a structured questionnaire.

The researchers found that 83.6 percent of participants used an Amsler grid chart, but only 39.3 percent used it once per week. Overall, 91.4 percent of participants used one or more personal electronic devices; 54.7 percent played games on them, 39 percent of whom played games once a day. Ninety-two percent of participants aged 50 to 69 years were willing to play a game to monitor vision, compared with 78 percent of those aged 70 years and older.

"A large proportion of AMD patients already use personal electronic devices," the authors write. "Gamification techniques are likely to increase compliance with self-monitoring, leading to earlier detection in the next generation of patients with neovascular AMD."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »